If You Invested $5,000 in Dexcom During the Coronavirus Market Crash, This Is How Much Money You'd Have Now

The March market crash and volatility that's followed have revealed the stocks that are recession-proof champions, while pulling back the curtain on companies far more vulnerable to economic adversity. Among healthcare companies that have continued to achieve profitable returns, Dexcom (NASDAQ: DXCM) is top-of-mind. The company is known for manufacturing and marketing continuous glucose monitoring (CGM) devices.

Dexcom has consistently surpassed the S&P 500's performance this year, experiencing substantial and relatively consistent gains during a roller-coaster year. As of Sept. 16, Dexcom has gained 82% year-to-date compared to the S&P 500's return of about 5.5%.

If you're curious about what a $5,000 investment in Dexcom back in March would be worth today, you've come to the right place. Let's dig deeper into Dexcom's performance over the past six months.

Source Fool.com